搜索优化
English
全部
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
腾讯网
9 天
创新多肽偶联药物达3期临床主要终点,今年递交新药申请
COMPETE是一项前瞻性、随机、含活性对照、开放标签的3期临床试验,旨在评估177Lu-edotreotide与依维莫司(everolimus)这一标准治疗方案相比的疗效和安全性。177Lu-edotreotide由镥177(一种发射β射线的放射性 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Deportation order blocked
US launches strikes in Yemen
Withdraws nomination
SK: Massive rallies erupt
Felony gun possession arrest
US expels SA ambassador
Electrical fire halts show
Permanently shuts route
Top intelligence agency visit
Man wins $50M over burns
RU, UKR launch attacks
Second protester arrested
Severe weather outbreak
Wins longest-ever Iditarod
Syed formally resentenced
Gold rises to new heights
Chiefs sign Tillery
Laceration hazard recall
Senate confirmation hearing
Trump signs funding bill
Consumer sentiment drops
Child abuse images sentence
Texas measles outbreak
Influencer leaves Australia
Coffee creamer recall
Cuba suffers power outage
Influential WY senator dies
Kupp signs with Seahawks
Pleads not guilty
ISIS leader killed in Iraq
反馈